BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 20448219)

  • 1. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
    Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
    Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide-mediated inhibition of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels.
    Chen W; Oberwinkler H; Werner F; Gaßner B; Nakagawa H; Feil R; Hofmann F; Schlossmann J; Dietrich A; Gudermann T; Nishida M; Del Galdo S; Wieland T; Kuhn M
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2121-9. PubMed ID: 23814119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
    Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
    Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
    Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
    Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.
    Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA
    Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice.
    Kilic A; Velic A; De Windt LJ; Fabritz L; Voss M; Mitko D; Zwiener M; Baba HA; van Eickels M; Schlatter E; Kuhn M
    Circulation; 2005 Oct; 112(15):2307-17. PubMed ID: 16216978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of natriuretic peptides in cardioprotection.
    Nishikimi T; Maeda N; Matsuoka H
    Cardiovasc Res; 2006 Feb; 69(2):318-28. PubMed ID: 16289003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
    Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
    Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.
    Li P; Wang D; Lucas J; Oparil S; Xing D; Cao X; Novak L; Renfrow MB; Chen YF
    Circ Res; 2008 Feb; 102(2):185-92. PubMed ID: 17991884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells.
    Chu CH; Tzang BS; Chen LM; Kuo CH; Cheng YC; Chen LY; Tsai FJ; Tsai CH; Kuo WW; Huang CY
    J Endocrinol; 2008 May; 197(2):381-90. PubMed ID: 18434368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
    Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
    Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
    Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
    J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
    Fiedler B; Wollert KC
    Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.
    Yamamoto K; Ikeda U; Shimada K
    J Mol Cell Cardiol; 1997 Sep; 29(9):2375-82. PubMed ID: 9299361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.
    Koitabashi N; Aiba T; Hesketh GG; Rowell J; Zhang M; Takimoto E; Tomaselli GF; Kass DA
    J Mol Cell Cardiol; 2010 Apr; 48(4):713-24. PubMed ID: 19961855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.